These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8513421)

  • 1. HMGCoA reductase inhibitors.
    Naylor D; McIsaac W
    Can J Cardiol; 1993 May; 9(4):288-90. PubMed ID: 8513421
    [No Abstract]   [Full Text] [Related]  

  • 2. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 4. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 5. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.
    Kamisako T; Adachi Y
    Am J Gastroenterol; 1995 Jul; 90(7):1187-8. PubMed ID: 7611234
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin therapy in clinical practice: new developments.
    Shepherd J
    Curr Opin Lipidol; 1995 Oct; 6(5):254-5. PubMed ID: 8520846
    [No Abstract]   [Full Text] [Related]  

  • 7. By the way, doctor. I have high cholesterol, and have been taking Mevacor (lovastatin) for two years. Recently, I was switched to Pravachol (pravastatin) because my insurance company would no longer pay for Mevacor. Is it as good?
    Nicholson CR
    Harv Womens Health Watch; 1999 Jun; 6(10):8. PubMed ID: 10233830
    [No Abstract]   [Full Text] [Related]  

  • 8. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and the acute-phase response.
    Munford RS
    N Engl J Med; 2001 Jun; 344(26):2016-8. PubMed ID: 11430332
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    Tsubokura M; Kami M
    N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Persistent CK-elevation after CSE inhibitor therapy].
    Faehling M; Leschke M
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1827-8. PubMed ID: 16902911
    [No Abstract]   [Full Text] [Related]  

  • 13. Are statins right for you?
    Gorman C
    Time; 2000 Nov; 156(19):102-3. PubMed ID: 11186855
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP; Bansal S; Blumenthal RS
    N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract]   [Full Text] [Related]  

  • 16. [HMA CoA reductase inhibitors].
    Kostner GM
    Wien Med Wochenschr; 1999; 149(5-6):109-10. PubMed ID: 10408000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cholesterol synthesis inhibitors: lowering of cholesterol for everybody?].
    Westendorp RG; Smelt AH
    Ned Tijdschr Geneeskd; 1996 Feb; 140(8):411-4. PubMed ID: 8720812
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlipidemia and arteriosclerosis].
    Mabuchi H
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):950-7. PubMed ID: 9648450
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.